Targeted siRNA therapy using cytoplasm-responsive nanocarriers and cell-penetrating peptides

Amand HL, Norden B, Fant K (2012) Functionalization with C-terminal cysteine enhanced transfection efficiency of cell-penetration peptides through dimmer formation. Biochem Biophys Res Commun 418:469–474

Aroui S, Brahim S, DeWaard M, Kenani A (2010) Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: a comparative study. Biochem Biophys Res Commun 391:419–425

Bechara C, Sagan S (2013) Cell-penetrating peptides: 20 years later, where do we stand? FEBS Lett 587:1693–1702

Beloor J, Choi CS, Nam HY, Park M, Kim SH, Jackson A, Lee KY, Kim SW, Kumar P, Lee S-K (2012) Arginine-engrafted biodegradable polymer for the systemic delivery of therapeutic siRNA. Biomaterials 33:1640–1650

Biswas S, Deshpande PP, Perche F, Dodwadkar NS, Sane SD, Torchilin VP (2013a) Octa-arginine-modified pegylated liposomal doxorubicin: an effective treatment strategy for non-small cell lung cancer. Cancer Lett 335:191–200

Biswas S, Dodwadkar NS, Deshpande PP, Parab S, Torchilin VP (2013b) Surface functionalization of doxorubicin-loaded liposomes with octa-arginine for enhanced anticancer activity. Eur J Pharm Biopharm 84:517–525

Breunig M, Hozsa C, Lungwitz U, Watanabe K, Umeda I, Kato H, Goepferich A (2008) Mechanistic investigation of poly(ethylene imine)-based siRNA delivery: disulfide bonds boost intracellular release of the cargo. J Control Release 130:57–63

Brooks H, Lebleu B, Vives E (2005) Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev 57:559–577

Burnett JC, Rossi JJ (2012) RNA-based therapeutics-current progress and future prospects. Chem Biol 27:60–71

Castanotto D, Tossi J (2009) The promises and pitfalls of RNA-interference-based therapeutics. Nature 457:426–433

Chen C-J, Wang JC, Zhao E-Y, Gao L-Y, Feng Q, Liu X-Y, Zhao Z-X, Ma X-F, Hou W-J, Zhang L-R, Lu W-L, Zhang Q (2013) Self-assembly cationic nanoparticles based on cholesterol-grafted bioreducible poly(amidoamine) for siRNA delivery. Biomaterials 34:5303–5316

Christensen LV, Chang C-W, Kim WJ, Kim SW (2006) Reducible poly(amido ethylenimine)s designed for triggered intracellular gene delivery. Bioconjug Chem 17:1233–1240

Dassie JP, Liu XY, Thomas GS, Whitaker RM, Thiel KW, Stockdale KR, Meyerholz DK, McCaffrey AP, McNamara JO II, Giangrande PH (2009) Systemic administration of optimized aptamers-siRNA chimeras promotes regression of PSMA-expressing tumors. Nat Biotechnol 27:839–849

Deng J-Z, Sun Y-X, Wang H-Y, Li C, Huang F-W, Cheng S-X, Zhuo R-X, Zhang X-Z (2011) Poly(β-amino amine) cross-linked PEIs as highly efficient gene vectors. Acta Biomater 7:2200–2208

Fonseca SB, Pereira MP, Kelley SO (2009) Recent advances in the use of cell-penetration peptides for medical and biological applications. Adv Drug Deliv Rev 61:953–964

Fougerolles AD, Vornlocher HP, Maraganore J, Lieberman J (2007) Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 6:443–453

Frankel AD, Pabo CO (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55:1189–1193

Furuhata M, Danev R, Nagayama K, Yamada Y, Kawakami H, Toma K, Hattori Y, Maitani Y (2008) Decaarginine-PEG-artificial lipid/DNA complex for gene delivery: nanostructure and transfection efficiency. J Nanosci Nanotechnol 8:2308–2315

Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K, Sugiura Y (2001) Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 276:5836–5840

Futaki S, Nakase I, Tadokoro A, Takeuchi T, Jones AT (2007) Arginine-rich peptides and their internalization mechanisms. Biochem Soc Trans 35:784–787

Goun EA, Pillow TH, Jones LR, Rothbard JB, Wender PA (2006) Molecular transporters: synthesis of oligoguanidinium transporters and their application to drug delivery and real-time imaging. Chem Biochem 7:1497–1515

Green M, Loewenstein PM (1988) Autonomous functional domains of chemically synthesized human immunodeficiency virus Tat trans-activator protein. Cell 55:1179–1188

Hyun H, Won Y-W, Kim K-M, Lee J, Lee M, Kim Y-H (2010) Therapeutic effects of a reducible poly(oligo-d-arginine) carrier with the heme oxygenase-1 gene in the treatment of hypoxic-ischemic brain injury. Biomaterials 31:9128–9134

Jackson AL, Linsley PS (2010) Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat Rev Drug Discov 9:57–67

Jones AT, Sayers EJ (2012) Cell entry of cell penetrating peptides: tales of tails wagging dogs. J Control Release 161:582–591

Judge AD, Robbins M, Tabakoli I, Levi J, Hu L, Fronda A, Maclachian L (2009) Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice. J Clin Investig 119:661–673

Kanazawa T, Takashima Y, Hirayama S, Okada H (2008) Effects of menstrual cycle on gene transfection through mouse vagina for DNA vaccine. Int J Pharm 360:164–170

Kanazawa T, Takashima Y, Tamura T, Tsuchiya M, Shibata Y, Udagawa H, Okada H (2010) Local gene expression and immune responses of vaginal DNA vaccination using a needle-free injector. Int J Pharm 396:11–16

Kanazawa T, Sugawara K, Tanaka K, Horiuchi S, Takashima Y, Okada H (2012) Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles. Eur J Pharm Biopharm 81:470–477

Kanazawa T, Tamura T, Yamazaki M, Takashima Y, Okada H (2013) Needle-free intravaginal DNA vaccination using a stearoyl oligopeptide carrier promotes local gene expression and immune responses. Int J Pharm 447:70–74

Kang HC, Kang H-J, Bae YH (2011) A reducible polycationic gene vector derived from thiolated low molecular weight branched polyethyleneimine linked by 2-iminothiolane. Biomaterials 32:1193–1203

Khalil LA, Futaki S, Niwa M, Baba Y, Kaji N, Kamiya H, Harashima H (2004) Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation. Gene Ther 11:636–644

Kim T-I, Kim SW (2011) Bioreducible polymers for gene delivery. React Funct Polym 71:344–349

Kim SH, Jeong JH, Ou M, Yockman JW, Kim SW, Bull DA (2008) Cardiomyocyte-targeted siRNA delivery by prostaglandin E2-Fas siRNA polyplexes formulated with reducible poly(amido amine) for preventing cardiomyocyte apoptosis. Biomaterials 29:4439–4446

Kim T-I, Ou M, Lee M, Kim SW (2009a) Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems. Biomaterials 30:658–664

Kim SH, Jeong JH, Kim TI, Kim SW, Bull DA (2009b) VEGF siRNA delivery system using arginine-grafted bioreducible poly(disulfide amine). Mol Pharm 6:718–726

Kim T-I, Lee M, Kim SW (2010) A guanidinylated bioreducible polymer with high nuclear localization ability for gene delivery systems. Biomaterials 31:1798–1804

Kim T-I, Rothmund T, Kissel T, Kim SW (2011) Bioreducible polymers with cell penetrating and endosome buffering functionality for gene delivery systems. J Control Release 152:110–119

Kiselev A, Egorova A, Laukkanen A, Baranov V, Urtti A (2013) Characterization of reducible peptide oligomers as carriers for gene delivery. Int J Pharm 441:736–747

Koren E, Torchilin VP (2012) Cell-penetrating peptides: breaking through to the other side. Trends Mol Med 18:385–393

Kuppusamy P, Li H, Ilangovan G, Cardounel AJ, Zweier JL, Yamada K, Krishna MC, Mitchell JB (2002) Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. Cancer Res 62:307–312

Kwon YJ (2012) Before and after endosomal escape: roles of stimuli-converting siRNA/polymer interactions in determining gene silencing efficiency. Acc Chem Res 45:1077–1088

Lin D, Jiang Q, Cheng Q, Huang Y, Huang P, Han S, Guo S, Liang Z, Dong A (2013) Polycation-detachable nanoparticles self-assembled from mPEG-PCL-g-SS- PDMAEMA for in vitro and in vivo siRNA delivery. Acta Biomater 9:7746–7757

Liu P, Yu H, Sun Y, Zhu M, Duan Y (2012) A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery. Biomaterials 33:4403–4412

Liu X, Liu C, Zhang W, Xie C, Wei G, Lu W (2013) Oligoarginine-modified biodegradable nanoparticles improve the intestinal absorption of insulin. Int J Pharm 448:159–167

Lo SL, Wang S (2008) An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection. Biomaterials 29:2408–2414

López-Fraga M, Wright N, Jiménez A (2008) RNA interference-based therapeutics: new strategies to fight infectious disease. Infect Disord Drug Targets 8:262–273

Martello F, Piest M, Engbersen JFJ, Ferruti P (2012) Effects of branched or linear architecture of bioreducible poly(amido amine)s on their in vitro gene delivery properties. J Control Release 164:372–379

Meade BR, Dowdy SF (2007) Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides. Adv Drug Deliv Rev 59:134–140

Meng F, Hennink WE, Zhong Z (2009) Reduction-sensitive polymers and bioconjugates for biomedical applications. Biomaterials 30:2180–2198

Midoux P, Pichon C, Yaouanc J-J, Jaffres P-A (2009) Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers. Br J Pharmacol 157:166–178

Milletti F (2012) Cell-penetrating peptides: classes, origin, and current landscape. Drug Discov Today 17:850–860

Mithchel DJ, Kim DT, Steinman L, Fathman CG, Rothbard JB (2000) Polyarginine enters cells more efficiently than other polycationic homopolymers. J Pept Res 56:318–325

Mok H, Park TG (2008) Self-crosslinked and reducible fusogenic peptides for intracellular delivery of siRNA. Biopolymers 89:881–888

Morishita M, Kamei N, Ehara J, Isowa K, Takayama K (2007) A novel approach using functional peptides for efficient intestinal absorption of insulin. J Control Release 118:177–184

Morris MC, Vidal P, Chaloin L, Heitz F, Divita G (1997) A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res 25:2730–2736

Morris MC, Depollier J, Mery J, Heitz F, Divita G (2001) A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol 19:1173–1176

Nakamura Y, Kogure K, Futaki S, Harashima H (2007) Octaarginine-modified multifunctional envelope-type nano device for siRNA. J Control Release 119:360–367

Nakase I, Tadokoro A, Kawabata N, Takeuchi T, Katoh H, Hiramoto K, Futaki S (2007) Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of action organization and macropinocytosis. Biochemistry 46:492–501

Nakase I, Tanaka G, Futaki S (2013) Cell-penetration peptides (CPPs) as a vector for the delivery of siRNAs into cells. Mol BioSyst 9:855–861

Nam HY, McGinn A, Kim P-H, Kim SW, Bull DA (2010) Primary cardiomyocyte targeted bioreducible polymer for efficient gene delivery to the myocardium. Biomaterials 31:8081–8087

Nam HY, Kim J, Kim S, Yockman JW, Kim SW, Bull DA (2011) Cell penetrating peptide conjugated bioreducible polymer for siRNA delivery. Biomaterials 32:5213–5222

Neu M, Germershaus O, Mao S, Voigt K-H, Behe M, Kissel T (2007) Crosslinked nanocarriers based upon poly(ethylene imine) for systemic plasmid delivery: in vitro characterization and in vivo studies in mice. J Control Release 118:370–380

Nori A, Jensen KD, Tijerina M, Kopecková P, Kopecek J (2003) Tat-conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to human ovarian carcinoma cells. Bioconjug Chem 14:44–50

Nounou MI, Emmanouil K, Chung S, Pham T, Lu Z, Bikram M (2010) Novel reducible linear l-lysine-modified copolymers as efficient nonviral vectors. J Control Release 143:326–334

Okada H, Ogawa T, Tanaka K, Kanazawa T, Takashima Y (2014) Cytoplasm-responsive delivery systems for siRNA using cell-penetrating peptide nanomicelles. J Drug Deliv Sci Technol 24:3–11

Orlacchio A, Bernardi G, Orlacchio A, Martino S (2007) RNA interference as a tool for Alzheimer’s disease therapy. Mini-Rev Med Chem 7:1166–1176

Ou M, Wang X-L, Xu R, Chang C-W, Bull DA, Kim SW (2008) Novel biodegradable poly(disulfide amine)s for gene delivery with high efficiency and low cytotoxicity. Bioconjug Chem 19:626–633

Ou M, Xu R, Kim SH, Bull DA, Kim SW (2009) A family of bioreducible poly(disulfide amine)s for gene delivery. Biomaterials 30:5804–5814

Ou M, Kim T-I, Yockman JW, Borden BA, Bull DA, Kim SW (2010) Polymer transfected primary myoblasts mediated efficient gene expression and angiogenic proliferation. J Control Release 142:61–69

Park K, Lee M-Y, Kim KS, Hahn SK (2010) Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate. Biomaterials 31:5258–5265

Ponnappa BC (2009) siRNA for inflammatory diseases. Curr Opin Investig Drugs 10:418–424

Rothbard JB, Jessop TC, Lewis RS, Murray BA, Wender PA (2004) Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells. J Am Chem Soc 126:9506–9507

Ryu JK, Choi MJ, Kim TI, Jin HR, Kwon KD, Batbold D, Song KM, Kwon MH, Yin GN, Lee M, Kim SW, Suh JK (2013) A guanidinylated bioreducible polymer as a novel gene carrier to the corpus cavernosum of mice with high-cholesterol diet-induced erectile dysfunction. Andrology 1:216–222

Saito G, Swanson JA, Lee KD (2003) Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv Drug Deliv Rev 55:199–214

Sakai N, Takeuchi T, Futaki S, Matile S (2005) direct observation of anion-mediated translocation of fluorescent oligoarginine carriers into and across bulk liquid and anionic bilayer membranes. ChemBioChem 6:114–122

Salomone F, Cardaelli F, Di Luca M, Boccardi C, Nifosi R, Bardi G, Di Bari L, Serresi M, Beltrarm F (2012) A novel chimeric cell-penetration peptide with membrane-disruptive properties for efficient endosomal escape. J Control Release 163:293–303

Semple SC, Akinc A, Chen J, Sandhu AP, Mui BL, Cho CK, Hope MJ (2010) Rational design of cationic lipids for siRNA delivery. Nat Biotechnol 28:172–176

Son S, Singha K, Kim WJ (2010) Bioreducible BPEI-SS-PEG-cNGR polymer as a tumor targeted nonviral gene carrier. Biomaterials 31:6344–6354

Son S, Namgung R, Kim J, Singha K, Kim WJ (2012) Bioreducible polymers for gene silencing and delivery. Acc Chem Res 45:1100–1112

Stevenson M, Ramos-Perez V, Singh S, Soliman M, Preece JA, Briggs SS, Read ML, Seymour LW (2008) Delivery of siRNA mediated by histidine-containing reducible polycations. J Control Release 130:46–56

Sun Y-X, Zeng X, Meng Q-F, Zhang X-Z, Cheng S-X, Zhuo R-X (2008) The influence of RGD addition on the gene transfer characteristics of disulfide-containing polyethyleneimine/DNA complexes. Biomaterials 29:4356–4365

Tanaka K, Kanazawa T, Ogawa T, Takashima Y, Fukuda T, Okada H (2010a) Disulfide crosslinked stearoyl carrier peptides containing arginine and histidine enhance siRNA uptake and gene silencing. Int J Pharm 398:219–224

Tanaka K, Kanazawa T, Shibata Y, Suda Y, Fukuda T, Takashima Y, Okada H (2010b) Development of cell-penetrating peptide-modified MPEG-PCL diblock copolymeric nanoparticles for systemic gene delivery. Int J Pharm 396:229–238

Tanaka K, Kanazawa T, Ogawa T, Suda Y, Takashima Y, Fukuda T, Okada H (2011) A novel, bio-reducible gene vector containing arginine and histidine enhances gene transfection and expression of plasmid DNA. Chem Pharm Bull 59:202–207

Tanaka K, Kanazawa T, Horiuchi S, Ando T, Sugawara K, Takashima Y, Seta Y, Okada H (2013) Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery. Int J Pharm 455:40–47

Tonges L, Lingor P, Egle R, Dietz GP, Fahr A, Bahr M (2006) Stearylated octaarginine and artificial virus-like particles for transfection of siRNA into primary rat neurons. RNA 12:1431–1438

Trubetskoy VS, Budker VG, Hanson LJ, Slattum PM, Wolff JA, Hagstrom JE (1998) Self-assembly of DNA-polymer complexes using template polymerization. Nucleic Acids Res 26:4178–4185

Uchida T, Kanazawa T, Kawai M, Takashima Y, Okada H (2011a) Therapeutic effects on atopic dermatitis by anti-RelA siRNA combined with functional peptides, Tat and AT1002. J Pharmacol Exp Ther 338:443–450

Uchida T, Kanazawa T, Kawai M, Takashima Y, Okada H (2011b) Development of an efficient siRNA transdermal delivery system using functional peptides, Tat and AT1002. Chem Pharm Bull 59:195–200

Varkouhi AK, Scholte M, Storm G, Haisma HJ (2011) Endosomal escape pathways for delivery of biologicals. J Control Release 151:220–228

Walrant A, Correia I, Jiao CY, Lequin O, Bent EH, Goasdoue N (2011) Different membrane behavior and cellular uptake of three basic arginine-rich peptides. Biochem Biophys Acta 1808:382–393

Wang X-L, Jensen R, Lu Z-R (2007) A novel environment-sensitive biodegradable polydisulfide with protonatable pendants for nucleic acid delivery. J Control Release 120:250–258

Wang X-L, Nguyen T, Gillespie D, Jensen R, Lu Z-R (2008) A multifunctional and reversible polymerizable carrier for efficient siRNA delivery. Biomaterials 29:15–22

Won Y-W, Kim HA, Lee M, Kim Y-H (2010) Reducible poly(oligo-d-arginine) for enhanced gene expression in mouse lung by intratracheal injection. Mol Ther 18:734–742

Won Y-W, Lim KS, Kim Y-H (2011a) Intracellular organelle-targeted non-viral gene delivery systems. J Control Release 152:99–109

Won Y-W, Kim K-M, An SS, Lee M, Ha Y, Kim Y-H (2011b) Suicide gene therapy using reducible poly(oligo-d-arginine) for the treatment of spinal cord tumors. Biomaterials 32:9766–9775

Won Y-W, Yoon S-M, Lee K-M, Kim Y-H (2011c) Poly(oligo-d-arginine) with internal disulfide linkages as a cytoplasm-sensitive carrier for siRNA delivery. Mol Ther 19:372–380

Wooddell CI, Rozema DB, Hossbach M, John M, Hamilton HL, Chu Q, Hegge JO, Klein JJ, Wakefield DH, Oropeza CE, Deckert J, Roehl I, Jahn-Hofmann K, Hadwiger P, Vornlocher HP, McLachaln A, Lewis DL (2013) Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection. Mol Ther 21:973–985

Wu G, Fang Y-Z, Yang S, Lupton JR, Turnere ND (2004) Glutathione metabolism and its implications for health. J Nutr 134:489–492

Xia HM, Gao XL, Gu GZ, Liu ZY, Zeng N, Hu QY (2011) Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration. Biomaterials 32:9888–9898

Xia W, Wang P, Lin C, Li Z, Gao X, Wang G, Zhao X (2012) Bioreducible polyethylenimine-delivered siRNA targeting human telomerase reverse transcriptase inhibits HepG2 cell growth in vitro and in vivo. J Control Release 157:427–436

Xue Y-N, Liu M, Peng L, Huang S-W, Zhuo R-X (2010) Improving gene delivery efficiency of bioreducible poly(amidoamine)s via grafting with dendritic poly(amidoamine)s. Macromol Biosci 10:404–414

Zhang ZH, Zhang YL, Zhou JP, Lu HX (2012) Solid lipid nanoparticles modified with stearic acid-octaarginine for oral administration of insulin. Int J Nanomed 7:3333–3339